Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform.
Efficace F, Patriarca A, Luppi M, Potenza L, Caocci G, Tafuri A, Fazio F, Cartoni C, Petrucci MT, Carmosino I, Moia R, Margiotta Casaluci G, Boggione P, Colaci E, Giusti D, Pioli V, Sparano F, Cottone F, De Fabritiis P, Ardu NR, Niscola P, Capodanno I, Leporace AP, Pelliccia S, Lugli E, La Sala E, Rigacci L, Santopietro M, Fozza C, Siragusa S, Breccia M, Fazi P, Vignetti M. Efficace F, et al. Among authors: santopietro m. Front Oncol. 2022 Mar 17;12:826040. doi: 10.3389/fonc.2022.826040. eCollection 2022. Front Oncol. 2022. PMID: 35372079 Free PMC article.
Unexpected erythroid and cytogenetic responses after discontinuation of a short course of lenalidomide as a result of severe skin rash in a patient with 5q syndrome.
Breccia M, Cannella L, Latagliata R, Loglisci G, Salaroli A, Santopietro M, Oliva EN, Alimena G. Breccia M, et al. Among authors: santopietro m. J Clin Oncol. 2011 May 10;29(14):e402-3. doi: 10.1200/JCO.2010.33.5083. Epub 2011 Feb 28. J Clin Oncol. 2011. PMID: 21357784 No abstract available.
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.
Latagliata R, Volpicelli P, Breccia M, Vozella F, Romano A, Montagna C, Molica M, Finsinger P, Carmosino I, Serrao A, Zacheo I, Santopietro M, Salaroli A, Alimena G. Latagliata R, et al. Among authors: santopietro m. Am J Hematol. 2015 Feb;90(2):105-8. doi: 10.1002/ajh.23879. Epub 2014 Nov 19. Am J Hematol. 2015. PMID: 25349084 Free article.
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.
Gurnari C, Piciocchi A, Soddu S, Bonanni F, Scalzulli E, Niscola P, Di Veroli A, Piccioni AL, Piedimonte M, Maiorana G, Salutari P, Cicconi L, Santopietro M, Gumenyuk S, Sarlo C, Fenu S, Tafuri A, Latagliata R, Fianchi L, Criscuolo M, Maciejewski JP, Maurillo L, Buccisano F, Breccia M, Voso MT. Gurnari C, et al. Among authors: santopietro m. Blood Cancer J. 2022 Sep 7;12(9):132. doi: 10.1038/s41408-022-00724-3. Blood Cancer J. 2022. PMID: 36071048 Free PMC article. No abstract available.
Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms: a collaborative retrospective study by pH-negative MPN latial group.
Breccia M, Petriccione L, Tatarelli C, De Muro M, Trawinska MM, Santopietro M, Spadea A, Di Veroli A, Scalzulli E, Paciaroni K, Tafuri A, Latagliata R, Andriani A, Di Napoli A. Breccia M, et al. Among authors: santopietro m. Leuk Lymphoma. 2022 Nov;63(11):2751-2753. doi: 10.1080/10428194.2022.2092859. Epub 2022 Jun 25. Leuk Lymphoma. 2022. PMID: 35758305 No abstract available.
A multicenter real-life study on anticoagulant treatment with direct oral anticoagulants in patients with Ph-negative myeloproliferative neoplasms.
Serrao A, Breccia M, Napolitano M, Fiori L, Santoro M, Scalzulli E, Santopietro M, Santoro C, Raso S, Chistolini A. Serrao A, et al. Among authors: santopietro m. Am J Hematol. 2020 Dec;95(12):E329-E332. doi: 10.1002/ajh.25990. Epub 2020 Sep 25. Am J Hematol. 2020. PMID: 32886820 Free article. Clinical Trial. No abstract available.
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
Breccia M, Cilloni D, Cannella L, Stefanizzi C, Tafuri A, Fama A, Santopietro M, Saglio G, Alimena G. Breccia M, et al. Among authors: santopietro m. Cancer Chemother Pharmacol. 2009 May;63(6):1161-3. doi: 10.1007/s00280-008-0858-8. Epub 2008 Nov 7. Cancer Chemother Pharmacol. 2009. PMID: 18989670
69 results